# Pharma Power: L'Architettura del Potere Sanitario Globale

> Come fondazioni private, PPP, revolving door FDA e network forum hanno ridisegnato la governance sanitaria mondiale

## Executive Summary

Questo report analizza il **network di potere nell'industria farmaceutica e nella salute globale**, identificando:

| Cluster | Entità Chiave | Pattern |
|---------|---------------|---------|
| **Fondazioni** | Gates Foundation ($77B), Wellcome Trust ($38B) | Funding → Influence |
| **PPP (Public-Private Partnership)** | GAVI, CEPI, Global Fund | Governance parallela |
| **WHO** | $6.8B budget, 83% voluntary | Donor capture |
| **Big Pharma** | Pfizer, J&J, Roche, Novartis, Moderna, BioNTech, AstraZeneca, Merck, GSK | Oligopolio, revolving door |
| **Regolatori** | FDA (65% industry-funded) | Regulatory capture |
| **Forum** | WEF (Hoffmann Co-Chair), PhRMA, CFR (Glocer) | Industry coordination |

**Tesi**: La salute globale post-2000 è governata da un sistema parallelo di PPP dominate da fondazioni private (Gates) e pharma, con WHO ridotta a dipendenza da donatori volontari, regolatori catturati dall'industria, e forum globali (WEF) con leadership diretta da Big Pharma (Hoffmann/Roche).

---

## Mappa del Network (Aggiornata)

```
                         GLOBAL HEALTH GOVERNANCE
                                  │
         ┌────────────────────────┼────────────────────────┐
         │                        │                        │
         ▼                        ▼                        ▼
   ┌───────────┐            ┌───────────┐            ┌───────────┐
   │ FONDAZIONI│            │    PPP    │            │  FORUM    │
   │  PRIVATE  │            │           │            │  GLOBALI  │
   └─────┬─────┘            └─────┬─────┘            └─────┬─────┘
         │                        │                        │
    ┌────┴────┐              ┌────┴────┐              ┌────┴────┐
    │         │              │         │              │         │
    ▼         ▼              ▼         ▼              ▼         ▼
┌───────┐ ┌───────┐      ┌──────┐ ┌──────┐      ┌──────┐ ┌──────┐
│ GATES │ │WELLCOME│     │ GAVI │ │ CEPI │      │ WEF  │ │PhRMA │
│ $77B  │ │ $38B  │      │      │ │      │      │      │ │      │
└───┬───┘ └───┬───┘      └───┬──┘ └───┬──┘      └───┬──┘ └───┬──┘
    │         │              │        │              │        │
    └────┬────┴──────────────┴────────┘              │        │
         │                                           │        │
         ▼                                           │        │
   ┌───────────┐                              ┌──────┴────────┴──────┐
   │    WHO    │◄────── Revolving Door ──────►│      BIG PHARMA      │
   │  (donor   │                              │                      │
   │  captured)│                              │ Pfizer  J&J  Moderna │
   └───────────┘                              │ Roche Novartis Merck │
         │                                    │ BioNTech AZ GSK      │
         │                                    └──────────┬───────────┘
         │                                               │
         └───────────────────────────────────────────────┘
                                │
                                ▼
                          ┌───────────┐
                          │    FDA    │
                          │   (65%    │
                          │ industry  │
                          │  funded)  │
                          └───────────┘
```

---

## 1. Gates Foundation: L'Architetto

### Profilo

| Metrica | Valore |
|---------|--------|
| **Endowment** | $77.2B (2024) |
| **Grant totali** | $83.3B dal 2000 |
| **Budget annuale** | ~$9B |
| **Chairman** | Bill Gates |
| **CEO** | Mark Suzman |
| **Sunset** | 2045 (chiusura annunciata) |

### Funding Network

```
GATES FOUNDATION ($77B)
        │
        ├──► WHO (~$830M/anno, ~10% budget, 2nd funder)
        │
        ├──► GAVI ($4.1B totali, ~20% budget, board seat)
        │
        ├──► CEPI (co-founder 2017)
        │
        ├──► BioNTech ($55M, 2019, HIV/TB programs)
        │
        └──► Global Fund ($2.5B+)
```

**Scheda**: [Gates Foundation](../docs/foundation/gates-foundation.md)

---

## 2. GAVI e CEPI: Il Modello PPP

### GAVI: Il Caso Barroso

```
JOSÉ MANUEL BARROSO
        │
        ├── 1993: GLT (Global Leader for Tomorrow) WEF
        ├── 2002-2004: PM Portogallo
        ├── 2004-2014: Presidente Commissione Europea
        ├── 2016-oggi: Chairman Goldman Sachs International
        └── 2021-oggi: Chairman GAVI
```

**Pattern**: Barroso è simultaneamente Chairman Goldman Sachs E Chairman GAVI.

**Scheda**: [GAVI](../docs/agency/gavi.md)

### CEPI: Nato a Davos

| Metrica | Valore |
|---------|--------|
| **Fondazione** | 2017 (WEF Davos) |
| **CEO** | Richard Hatchett (ex-BARDA, NSC, HSC) |
| **Funding totale** | $3.1B |

**Scheda**: [CEPI](../docs/agency/cepi.md)

---

## 3. WHO: Donor Capture

### Il Problema Strutturale

| Metrica | Valore |
|---------|--------|
| **Budget 2024-25** | $6.83B |
| **Voluntary contributions** | **83%** |
| **Assessed contributions** | 17% |

**Implicazione**: Chi paga di più (USA, Germania, Gates) controlla l'agenda.

**Scheda**: [WHO](../docs/agency/who.md)

---

## 4. Big Pharma: Profiles Completi

### Overview

| Azienda | HQ | Revenue 2024 | CEO | Pattern Chiave |
|---------|-----|--------------|-----|----------------|
| [Pfizer](../docs/pharma/pfizer.md) | USA | $63.6B | Albert Bourla | Gottlieb (ex-FDA) in board |
| [J&J](../docs/pharma/johnson-johnson.md) | USA | $88.8B | Joaquin Duato | McClellan (ex-FDA) in board |
| [Moderna](../docs/pharma/moderna.md) | USA | $3.2B | Stephane Bancel | Hahn (ex-FDA) → Flagship, Rubenstein (CFR) in board |
| [BioNTech](../docs/pharma/biontech.md) | DEU | - | Ugur Sahin | Strungmann twins control (~50%) |
| [Roche](../docs/pharma/roche.md) | CHE | $68.7B | Thomas Schinecker | **Hoffmann WEF Co-Chair** |
| [Novartis](../docs/pharma/novartis.md) | CHE | $51.7B | Vas Narasimhan | **PhRMA Chair** |
| [AstraZeneca](../docs/pharma/astrazeneca.md) | UK | $45.8B | Pascal Soriot | **Henney (ex-FDA)** in board, WEF |
| [Merck](../docs/pharma/merck.md) | USA | $64.2B | Robert Davis | **Glocer (CFR, Morgan Stanley)**, Warden (Northrop) |
| [GSK](../docs/pharma/gsk.md) | UK | £31.4B | Emma Walmsley | **Microsoft board**, Symonds (ex-CFO Novartis+AZ) |

### Basel Pharma Hub

```
BASEL, SWITZERLAND
        │
        ├── ROCHE ($68.7B)
        │       └── Hoffmann family control (50%)
        │       └── Andre Hoffmann = WEF Co-Chair
        │
        └── NOVARTIS ($51.7B)
                └── Narasimhan = PhRMA Chair

        TOTAL: $120B revenue in una città
```

---

## 5. FDA Revolving Door: Pattern Completo

### I 4 Vaccini COVID Principali

```
VACCINO COVID         EX-FDA COMMISSIONER         DESTINAZIONE

    Pfizer       ───►  Scott Gottlieb (2017-19)  ───►  Board Pfizer
                                                       (85 giorni dopo)

    J&J          ───►  Mark McClellan (2002-04)  ───►  Board J&J
                                                       (dal 2013)

    Moderna      ───►  Stephen Hahn (2019-21)    ───►  Flagship Pioneering
                                                       (incubatore Moderna)

    AstraZeneca  ───►  Jane Henney (1999-01)     ───►  Board AstraZeneca
                                                       (prima donna FDA)
```

**Pattern**: Tutte e 4 le aziende con vaccini COVID approvati hanno ex-FDA Commissioner nei rispettivi board/incubatori.

### FDA Funding Model

| Fonte | % Budget |
|-------|----------|
| **Industry user fees** | **65%** |
| Governo federale | 35% |

> "When your No. 1 major employer after you leave is sitting across the table, you're not going to be a hard-ass when you regulate." - Vinay Prasad, M.D.

### Commissioners Post-2000: Tutti in Industria

| Commissioner | Mandato | Dopo FDA |
|--------------|---------|----------|
| **Jane Henney** | 1999-01 | **AstraZeneca board** (prima donna FDA) |
| Mark McClellan | 2002-04 | J&J board |
| Andrew von Eschenbach | 2006-09 | BioTime, Viamet boards |
| Margaret Hamburg | 2009-15 | Alnylam board, **GAVI board**, **CFR** |
| Scott Gottlieb | 2017-19 | Pfizer board, Illumina, AEI |
| Stephen Hahn | 2019-21 | Flagship Pioneering (Moderna) |
| Robert Califf | 2016-17, 2022- | Verily (Alphabet) $2.7M |

### FDA → Big Pharma COVID Vaccines (Completo)

| Vaccino | Ex-FDA Commissioner | Destinazione |
|---------|---------------------|--------------|
| Pfizer | Scott Gottlieb (2017-19) | Pfizer board (85 giorni) |
| J&J | Mark McClellan (2002-04) | J&J board (dal 2013) |
| Moderna | Stephen Hahn (2019-21) | Flagship Pioneering (incubatore) |
| **AstraZeneca** | **Jane Henney (1999-01)** | **AstraZeneca board** |

**Pattern**: 4 su 4 vaccini COVID principali hanno ex-FDA Commissioner nei rispettivi board.

**Scheda**: [FDA](../docs/agency/fda.md)

---

## 6. WEF: Pharma al Vertice

### Leadership WEF 2025

| Ruolo | Nome | Background |
|-------|------|------------|
| **Co-Chair** | [Larry Fink](../docs/persons/larry-fink.md) | CEO BlackRock |
| **Co-Chair** | [Andre Hoffmann](../docs/persons/andre-hoffmann.md) | Vice-Chairman **Roche** |

**Pattern**: Il forum globale più influente è co-guidato dal CEO del più grande asset manager E dall'erede della dinastia farmaceutica svizzera.

### Andre Hoffmann: Il Ponte

```
ANDRE HOFFMANN
        │
        ├── PHARMA: Vice-Chairman Roche (5a generazione)
        │
        ├── WEF: Co-Chair (con Larry Fink)
        │
        ├── ENVIRONMENT: Ex-VP WWF (18 anni)
        │
        └── THINK TANKS: Club of Rome, INSEAD
```

---

## 7. PhRMA: La Lobby

### Chair Rotation

| Anno | PhRMA Chair | Azienda |
|------|-------------|---------|
| 2022 | Albert Bourla | Pfizer |
| 2023- | **Vas Narasimhan** | **Novartis** |
| 2025 | Thomas Schinecker (next) | Roche |

**Pattern**: I CEO delle Big Pharma si alternano come Chair della lobby USA.

---

## 8. Nuovi Pattern: CFR, Defense, Tech

### CFR-Wall Street-Pharma Triangle (Merck)

```
THOMAS GLOCER
    │
    ├── MERCK (Lead Director)
    │       └── $64B pharma
    │
    ├── MORGAN STANLEY (Lead Director)
    │       └── $177B bank
    │
    └── CFR (Member)
            └── Foreign policy establishment
```

**Pattern**: Glocer collega simultaneamente Big Pharma, Wall Street e foreign policy.

### Defense-Pharma Crosslink (Merck)

```
KATHY WARDEN
    │
    ├── NORTHROP GRUMMAN (CEO/Chairman)
    │       └── 5° contractor difesa USA ($41B)
    │
    └── MERCK (Board)
            └── 4° pharma USA ($64B)
```

**Pattern**: CEO del 5° contractor difesa siede nel board del 4° pharma.

### Tech-Pharma Board Crossover (GSK)

```
EMMA WALMSLEY
    │
    ├── GSK (CEO)
    │       └── £31B pharma
    │
    └── MICROSOFT (Board)
            └── Big Tech + healthcare AI
```

**Pattern**: CEO Big Pharma (prima donna) siede in board Big Tech.

### Executive Rotation Pharma (GSK)

```
JONATHAN SYMONDS (GSK Chairman)
    │
    ├── AstraZeneca (ex-CFO)
    │
    ├── Novartis (ex-CFO)
    │
    └── GSK (Chairman)

LUKE MIELS (GSK incoming CEO)
    │
    ├── AstraZeneca (ex)
    ├── Roche (ex)
    ├── Sanofi (ex)
    └── GSK (CEO 2026)
```

**Pattern**: Il settore pharma e' un club chiuso con executive che ruotano tra le stesse 6-7 aziende.

---

## 9. Moderna: Il Caso Estremo

### Network Connections

```
MODERNA
    │
    ├── FLAGSHIP PIONEERING (incubatore)
    │       ├── Noubar Afeyan (CEO Flagship, Chairman Moderna)
    │       └── Stephen Hahn (ex-FDA Commissioner → CMO Flagship)
    │
    ├── BOARD CONNECTIONS
    │       └── DAVID RUBENSTEIN
    │               ├── Co-founder Carlyle Group
    │               ├── Chairman CFR
    │               ├── Bilderberg member
    │               ├── Trilateral member
    │               └── WEF board
    │
    ├── GOVERNMENT FUNDING
    │       ├── DARPA ($25M, 2013)
    │       ├── BARDA ($955M)
    │       └── Totale: ~$6B pubblici
    │
    └── NIH CO-OWNERSHIP
            └── Patent vaccino co-owned da NIH
```

**Pattern**: Moderna collega DARPA, venture capital, ex-FDA, CFR/Bilderberg/Trilateral (via Rubenstein), e funding pubblico massiccio.

**Scheda**: [Moderna](../docs/pharma/moderna.md)

---

## 10. Pattern Identificati

### 1. Regulatory Capture Sistemica

```
FDA (65% industry-funded)
        │
        ├── 9/10 Commissioners → industria
        │
        ├── User fees = industry pays for review
        │
        └── "Behind the scenes" lobbying permesso
```

### 2. Forum come Governance Parallela

| Forum | Ruolo Pharma |
|-------|--------------|
| **WEF** | Andre Hoffmann (Roche) Co-Chair |
| **PhRMA** | CEO rotation (Bourla → Narasimhan → Schinecker) |
| **CFR** | Margaret Hamburg board, Rubenstein Chairman |
| **Bilderberg** | Rubenstein (Moderna board) |

### 3. PPP Bypass Accountability

```
GOVERNI ──► ONU/WHO ──► Accountability statale

vs.

GATES + PHARMA ──► GAVI/CEPI ──► Accountability donatori
```

### 4. Asset Manager Governance

```
BIG THREE (Vanguard, BlackRock, State Street)
        │
        ├── Top shareholders tutte Big Pharma
        │
        ├── Tim Buckley (ex-CEO Vanguard) → Pfizer board
        │
        ├── Cyrus Taraporevala (ex-CEO SSGA) → Pfizer board
        │
        └── Larry Fink (BlackRock) = WEF Co-Chair con Hoffmann (Roche)
```

### 5. Revolving Door Multilaterale

| Da | A | Esempio |
|----|---|---------|
| FDA Commissioner | Pharma board | Gottlieb → Pfizer |
| EU Commission President | Pharma PPP + Goldman | Barroso → GAVI + GS |
| US Security Council | Global Health PPP | Hatchett → CEPI |
| FDA Commissioner | Pharma incubator | Hahn → Flagship |

---

## 11. Entità nel Database

### Organizzazioni (Schede Complete)

| ID | Tipo | Scheda |
|----|------|--------|
| [gates-foundation](../docs/foundation/gates-foundation.md) | Foundation | ✅ |
| [gavi](../docs/agency/gavi.md) | Agency | ✅ |
| [who](../docs/agency/who.md) | Agency | ✅ |
| [cepi](../docs/agency/cepi.md) | Agency | ✅ |
| [fda](../docs/agency/fda.md) | Agency | ✅ |
| [pfizer](../docs/pharma/pfizer.md) | Pharma | ✅ |
| [johnson-johnson](../docs/pharma/johnson-johnson.md) | Pharma | ✅ |
| [moderna](../docs/pharma/moderna.md) | Pharma | ✅ |
| [biontech](../docs/pharma/biontech.md) | Pharma | ✅ |
| [roche](../docs/pharma/roche.md) | Pharma | ✅ |
| [novartis](../docs/pharma/novartis.md) | Pharma | ✅ |
| [flagship-pioneering](../docs/private-equity/flagship-pioneering.md) | PrivateEquity | Stub |
| [astrazeneca](../docs/pharma/astrazeneca.md) | Pharma | ✅ |
| [merck](../docs/pharma/merck.md) | Pharma | ✅ |
| [gsk](../docs/pharma/gsk.md) | Pharma | ✅ |
| [morgan-stanley](../docs/bank/morgan-stanley.md) | Bank | Stub |
| [northrop-grumman](../docs/company/northrop-grumman.md) | Company | Stub |
| [microsoft](../docs/company/microsoft.md) | Company | Stub |

### Persone Chiave

| ID | Ruolo | Scheda |
|----|-------|--------|
| albert-bourla | CEO Pfizer | Stub |
| scott-gottlieb | Ex-FDA → Pfizer | Stub |
| joaquin-duato | CEO J&J | Stub |
| mark-mcclellan | Ex-FDA → J&J | Stub |
| stephane-bancel | CEO Moderna | Stub |
| stephen-hahn | Ex-FDA → Flagship | Stub |
| noubar-afeyan | Flagship/Moderna | Stub |
| david-rubenstein | Moderna board, CFR Chair | Esistente |
| ugur-sahin | CEO BioNTech | Stub |
| ozlem-tureci | CMO BioNTech | Stub |
| andre-hoffmann | Roche, **WEF Co-Chair** | Stub |
| thomas-schinecker | CEO Roche | Stub |
| vas-narasimhan | CEO Novartis, **PhRMA Chair** | Stub |
| jose-barroso | GAVI Chair, Goldman | Esistente |
| pascal-soriot | CEO AstraZeneca, WEF | Stub |
| jane-henney | **Ex-FDA → AstraZeneca** | Stub |
| michel-demare | Chairman AstraZeneca | Stub |
| robert-davis | CEO/Chairman Merck | Stub |
| thomas-glocer | **Lead Director Merck + Morgan Stanley, CFR** | Stub |
| kathy-warden | **CEO Northrop Grumman → Merck board** | Stub |
| emma-walmsley | CEO GSK, **Microsoft board** | Stub |
| jonathan-symonds | Chairman GSK, ex-CFO Novartis+AZ | Stub |
| luke-miels | Incoming CEO GSK | Stub |

---

## 12. Implicazioni

### 1. Unelected Power

| Posizione | Accountability |
|-----------|----------------|
| WEF Co-Chair (Hoffmann, Fink) | Nessuna elettorale |
| PhRMA Chair (Narasimhan) | Solo shareholders |
| Gates Foundation | Fondazione privata |
| GAVI/CEPI | Donatori |

### 2. Circolarità Governance

```
PHARMA CEO ──► PhRMA Chair ──► Lobbying ──► FDA policy
     │                                          │
     └──────────────────────────────────────────┘
                         │
                    FDA Commissioner
                         │
                         ▼
                    Pharma Board
```

### 3. Public Money, Private Control

| Entità | Funding Pubblico | Controllo |
|--------|------------------|-----------|
| Moderna | ~$6B USA | Flagship, shareholders |
| BioNTech | CEPI $145M | Strungmann twins |
| J&J vaccine | BARDA $1B+ | J&J shareholders |

---

## 13. Domande Aperte

1. **WEF post-Schwab**: Hoffmann + Fink consolidano pharma + finance al vertice?
2. **Gates Foundation 2045**: Chi eredita l'influenza?
3. **FDA reform**: Kennedy/Trump cambieranno revolving door?
4. **mRNA control**: Chi controlla la piattaforma tecnologica?
5. **Basel concentration**: Antitrust su hub Roche/Novartis?

---

## Fonti

### Istituzioni
- [Gates Foundation](https://www.gatesfoundation.org/)
- [GAVI](https://www.gavi.org/)
- [WHO](https://www.who.int/)
- [CEPI](https://cepi.net/)
- [FDA](https://www.fda.gov/)
- [WEF](https://www.weforum.org/)
- [PhRMA](https://phrma.org/)

### Aziende
- [Pfizer](https://www.pfizer.com/)
- [J&J](https://www.jnj.com/)
- [Moderna](https://www.modernatx.com/)
- [BioNTech](https://www.biontech.com/)
- [Roche](https://www.roche.com/)
- [Novartis](https://www.novartis.com/)
- [AstraZeneca](https://www.astrazeneca.com/)
- [Merck](https://www.merck.com/)
- [GSK](https://www.gsk.com/)

### Analisi Revolving Door
- [STAT News - Gottlieb Pfizer](https://www.statnews.com/pharmalot/2019/06/27/scott-gottlieb-pfizer-board-fda/)
- [STAT News - Hahn Flagship](https://www.statnews.com/2021/06/15/steve-hahn-fda-moderna-flagship-pioneering/)
- [Stanford Law - FDA Revolving Door](https://law.stanford.edu/publications/fdas-revolving-door-reckoning-and-reform/)
- [NPR - FDA to Industry](https://www.npr.org/sections/health-shots/2016/09/28/495694559/a-look-at-how-the-revolving-door-spins-from-fda-to-industry)

### WEF/Forum
- [WEF Leadership](https://www.weforum.org/about/leadership-and-governance/)
- [Sociable - Andre Hoffmann](https://sociable.co/government-and-policy/who-is-andre-hoffmann-wef-big-pharma-agenda-2030-stakeholder-economy/)

---

*Report creato: Dicembre 2025*
*Ultimo aggiornamento: 9 Dicembre 2025*
*Entità documentate: 9 Pharma, 5 Agency, 1 Foundation, 3 stub (18 org totali), 25+ persone chiave*
